|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income: | ||
| Interest income | ||
| Other income, net | ||
| Total other income, net | ||
| Net loss before provision for income taxes | ||
| Provision for income taxes | ||
| Net loss | ||
| Other comprehensive loss: | ||
| Unrealized loss on available-for-sale securities, net of tax of $0 | ||
| Total other comprehensive loss | ||
| Comprehensive loss | ||
| Cumulative dividends on convertible preferred stock | ||
| Gain on extinguishment of Series A, Series B and Series C convertible preferred stock | ||
| Undistributed earnings allocable to participating securities | ||
| Net loss attributable to common stockholders | ||
| Cumulative Dividends On Series B and Series C Convertible Preferred Stock | ||
| Gain on extinguishment of Series B and Series C convertible preferred stock | ||
| Undistributed earnings allocable to Series B and Series C participating securities | ||
| Net income (loss) attributable to common stockholders, diluted | ||
| Net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Weighted-average shares of common stock outstanding, basic | ||
| Weighted-average shares of common stock outstanding, diluted |
Loading...
